Though based on small numbers in a halted trial, ECMO was associated with reduced mortality for PCI patients in MI-related cardiogenic shock, results of the EURO SHOCK trial suggest.
Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new registry data suggest.